Canopy Growth (CGC) Net Cash Flow Growth (3y) (2022 - 2025)
Canopy Growth (CGC) Net Cash Flow Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -62.71% |
| 10 | Canopy Growth | 272.05 Mn | 6.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.02% |
| Jun 30, 2025 | 27.04% |
| Dec 31, 2024 | 34.98% |
| Sep 30, 2024 | -49.86% |
| Jun 30, 2024 | 26.34% |
| Mar 31, 2024 | -77.97% |
| Dec 31, 2023 | -36.80% |
| Sep 30, 2023 | -3.51% |
| Jun 30, 2023 | 30.48% |
| Mar 31, 2023 | 42.76% |
| Dec 31, 2022 | -34.17% |
| Sep 30, 2022 | 32.56% |
| Jun 30, 2022 | 24.67% |